Ticamar Tablet
Marketer
Omarion Pharmaceuticals Pvt Ltd.
Salt Composition
Ticagrelor (90mg)
Overview Ticamar Tablet
CardioGuard tablets are classified as antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiovascular disease. CardioGuard is also indicated for patients recovering from a heart attack, experiencing unstable angina (severe chest pain), or who have recently undergone cardiac stenting. Its purpose is to reduce the likelihood of subsequent heart attacks, strokes, or clot formation within stents. Concurrent use with aspirin, another antiplatelet medication, will be prescribed by your physician. CardioGuard can be ingested with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of well-being, as discontinuation increases the risk of recurrent cardiovascular events. The most frequent adverse effect is increased bleeding tendency; injuries may bleed more profusely and for a longer duration. While usually mild and self-limiting, prolonged or excessive bleeding should be reported to your physician. Similarly, some individuals may experience mild shortness of breath, which typically subsides with ongoing treatment; however, worsening or persistent symptoms require medical attention. CardioGuard is contraindicated in patients with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor prior to commencing treatment.
Primary Ingredients of Ticamar Tablet
The provided text is "undefined". Therefore, no rephrasing is possible.
Uses of Ticamar Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticamar Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticamar Tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Ticamar Tablet:
- Bleeding
- Breathlessness
How to use Ticamar Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ticamar Tablet whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Ticamar Tablet works:
Aggrenox tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombi and consequently lowering the incidence of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Alcohol consumption alongside Ticamar Tablet requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ticamar Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticamar Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticamar Tablet.
KidneySAFE IF PRESCRIBED
Ticamar tablets pose no safety concerns for individuals with kidney disease and require no dosage modification. Data regarding Ticamar tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ticamar Tablets, potentially requiring dosage modification under medical supervision. Ticamar Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ticamar Tablet :
Should you forget a Ticamar Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ticamar Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | ADP receptor antagonists (P2Y12 inhibitors) |



